Alector Inc. (ALEC) NASDAQ
$6.88 0.85 (14.10%)
Market Cap: $576.75M
As of 09/22/23 04:00 PM EDT. Market closed.
Alector Inc. (ALEC)
NASDAQ
$6.88
0.85 (14.10%)
Market Cap: $576.75M
As of 09/22/23 04:00 PM EDT. Market closed.
we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's ... read more
we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's disease. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
294
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
294
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
URL
Address
151 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1841.
PRICE CHART FOR ALECTOR INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$6.03
Days Range
$6.28 - $6.93
52 week range
$4.98 - $10.07
Volume
5,881
Avg. Volume (30 days)
901,289
Market Cap
$576.75M
Dividend Yield
-
P/E
-
Shares Outstanding
83,830,300
Open
-
Previous Close
$6.03
Days Range
$6.28 - $6.93
52 week range
$4.98 - $10.07
Volume
5,881
Avg. Volume (30 days)
901,289
Market Cap
$576.75M
Dividend Yield
-
P/E
-
Shares Outstanding
83,830,300
FINANCIAL STATEMENTS FOR ALECTOR INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ALECTOR INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | Sep 11, 2023 | Sale | $6.00 | 500,000 | 3,000,000 | 10,853,817 | Sep 13, 2023, 04:33 PM |
| MCGUIRE TERRANCE | Director | Sep 11, 2023 | Sale | $6.00 | 500,000 | 3,000,000 | 10,853,817 | Sep 13, 2023, 04:29 PM |
| Rosenthal Arnon | Chief Executive Officer | Sep 05, 2023 | Sale | $5.19 | 5,647 | 29,333 | 1,645,448 | Sep 06, 2023, 07:18 PM |
| Kenkare-Mitra Sara | President and Head of R&D | Sep 05, 2023 | Sale | $5.19 | 6,214 | 32,277 | 177,935 | Sep 06, 2023, 07:17 PM |
| Romano Gary | Chief Medical Officer | Sep 05, 2023 | Sale | $5.19 | 2,771 | 14,393 | 99,349 | Sep 06, 2023, 07:16 PM |
| GRASSO MARC | Chief Financial Officer | Sep 05, 2023 | Sale | $5.19 | 1,114 | 5,786 | 32,247 | Sep 06, 2023, 07:14 PM |
| Kenkare-Mitra Sara | President and Head of R&D | Jun 02, 2023 | Sale | $6.90 | 4,092 | 28,250 | 184,149 | Jun 05, 2023, 06:54 PM |
| GRASSO MARC | Chief Financial Officer | Jun 02, 2023 | Sale | $6.90 | 1,050 | 7,249 | 33,361 | Jun 05, 2023, 06:52 PM |
| Romano Gary | Chief Medical Officer | Jun 02, 2023 | Sale | $6.90 | 2,617 | 18,067 | 102,120 | Jun 05, 2023, 06:50 PM |
| Rosenthal Arnon | Chief Executive Officer | Jun 02, 2023 | Sale | $6.90 | 5,255 | 36,279 | 1,651,095 | Jun 05, 2023, 06:48 PM |
| Rosenthal Arnon | Chief Executive Officer | Mar 17, 2023 | Sale | $6.22 | 15,186 | 94,428 | 1,656,350 | Mar 21, 2023, 08:35 PM |
| Romano Gary | Chief Medical Officer | Mar 02, 2023 | Sale | $8.32 | 3,238 | 26,933 | 104,737 | Mar 03, 2023, 08:56 PM |
| Romano Gary | Chief Medical Officer | Dec 02, 2022 | Sale | $8.71 | 2,145 | 18,679 | 107,975 | Mar 03, 2023, 08:56 PM |
| Kenkare-Mitra Sara | President and Head of R&D | Mar 02, 2023 | Sale | $8.32 | 10,124 | 84,216 | 188,241 | Mar 03, 2023, 08:53 PM |
| GRASSO MARC | Chief Financial Officer | Mar 02, 2023 | Sale | $8.32 | 1,291 | 10,739 | 34,411 | Mar 03, 2023, 08:49 PM |
| Rosenthal Arnon | Chief Executive Officer | Mar 02, 2023 | Sale | $8.32 | 5,849 | 48,651 | 1,628,546 | Mar 03, 2023, 08:47 PM |
| Yaffe Kristine | Director | Sep 10, 2021 | Option Exercise | $18.10 | 2,000 | 36,200 | 2,000 | Jan 31, 2023, 07:17 PM |
| Romano Gary | Chief Medical Officer | Sep 02, 2022 | Sale | $10.62 | 2,177 | 23,120 | 90,073 | Sep 07, 2022, 04:17 PM |
| King Robert | Chief Development Officer | Sep 02, 2022 | Sale | $10.62 | 176 | 1,869 | 529,295 | Sep 07, 2022, 04:15 PM |
| King Robert | Chief Development Officer | Jun 02, 2022 | Sale | $8.71 | 177 | 1,542 | 529,471 | Jun 06, 2022, 04:52 PM |
| King Robert | Chief Development Officer | Mar 01, 2022 | Sale | $15.57 | 287 | 4,468 | 528,404 | Mar 03, 2022, 05:41 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 13, 2021 | Option Exercise | $17.23 | 75,000 | 1,292,250 | 177,598 | Dec 14, 2021, 08:23 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 10, 2021 | Option Exercise | $17.23 | 75,000 | 1,292,250 | 177,598 | Dec 14, 2021, 08:23 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 13, 2021 | Sale | $21.24 | 75,000 | 1,593,149 | 113,496 | Dec 14, 2021, 08:23 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 10, 2021 | Sale | $21.76 | 75,000 | 1,632,167 | 111,472 | Dec 14, 2021, 08:23 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 09, 2021 | Option Exercise | $17.23 | 75,000 | 1,292,250 | 177,598 | Dec 10, 2021, 07:20 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 08, 2021 | Option Exercise | $12.09 | 75,000 | 906,493 | 177,598 | Dec 10, 2021, 07:20 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 08, 2021 | Sale | $22.79 | 75,000 | 1,709,316 | 141,087 | Dec 10, 2021, 07:20 PM |
| SULIMAN SHEHNAAZ | President and COO | Dec 09, 2021 | Sale | $22.82 | 75,000 | 1,711,843 | 105,241 | Dec 10, 2021, 07:20 PM |
| King Robert | Chief Development Officer | Dec 01, 2021 | Sale | $20.09 | 250 | 5,023 | 528,691 | Dec 03, 2021, 05:08 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 11, 2021 | Sale | $25.00 | 55,000 | 1,375,000 | 1,972,875 | Nov 12, 2021, 06:36 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 10, 2021 | Sale | $25.00 | 55,000 | 1,375,000 | 2,027,875 | Nov 12, 2021, 06:36 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 09, 2021 | Sale | $25.00 | 100,000 | 2,500,000 | 2,082,875 | Nov 10, 2021, 07:07 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 08, 2021 | Sale | $25.00 | 100,000 | 2,500,000 | 2,137,875 | Nov 10, 2021, 07:07 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 05, 2021 | Sale | $25.00 | 100,000 | 2,500,000 | 2,192,875 | Nov 08, 2021, 06:39 PM |
| Rosenthal Arnon | Chief Executive Officer | Nov 04, 2021 | Sale | $25.00 | 100,000 | 2,500,000 | 2,247,875 | Nov 08, 2021, 06:39 PM |
| Rosenthal Arnon | Chief Executive Officer | Sep 23, 2021 | Sale | $25.10 | 9,625 | 241,567 | 2,302,875 | Sep 23, 2021, 09:12 PM |
| Rosenthal Arnon | Chief Executive Officer | Sep 22, 2021 | Sale | $25.33 | 100,000 | 2,533,188 | 2,317,783 | Sep 23, 2021, 09:12 PM |
| Rosenthal Arnon | Chief Executive Officer | Sep 20, 2021 | Sale | $25.80 | 100,000 | 2,580,391 | 2,520,546 | Sep 22, 2021, 04:54 PM |
| Rosenthal Arnon | Chief Executive Officer | Sep 21, 2021 | Sale | $26.11 | 100,000 | 2,611,437 | 2,420,962 | Sep 22, 2021, 04:54 PM |
| Paul Robert | Chief Medical Officer | Aug 09, 2021 | Option Exercise | $10.69 | 22,950 | 245,245 | 257,269 | Aug 11, 2021, 06:23 PM |
| Paul Robert | Chief Medical Officer | Aug 09, 2021 | Sale | $27.18 | 22,950 | 623,767 | 234,619 | Aug 11, 2021, 06:23 PM |
| SCHELLER RICHARD H | Director | Aug 05, 2021 | Option Exercise | $10.14 | 56,260 | 570,476 | 56,260 | Aug 09, 2021, 06:13 PM |
| SCHELLER RICHARD H | Director | Aug 05, 2021 | Sale | $27.68 | 56,260 | 1,557,341 | 3,392 | Aug 09, 2021, 06:13 PM |
| SCHELLER RICHARD H | Director | Jul 02, 2021 | Sale | $31.14 | 9,981 | 310,808 | 0 | Aug 09, 2021, 06:13 PM |
| Paul Robert | Chief Medical Officer | Jul 07, 2021 | Option Exercise | $12.15 | 29,749 | 361,340 | 264,068 | Jul 08, 2021, 06:24 PM |
| Paul Robert | Chief Medical Officer | Jul 06, 2021 | Option Exercise | $17.15 | 30,000 | 514,500 | 264,319 | Jul 08, 2021, 06:24 PM |
| Paul Robert | Chief Medical Officer | Jul 06, 2021 | Sale | $37.31 | 30,000 | 1,119,167 | 254,095 | Jul 08, 2021, 06:24 PM |
| Paul Robert | Chief Medical Officer | Jul 07, 2021 | Sale | $38.70 | 29,749 | 1,151,237 | 259,168 | Jul 08, 2021, 06:24 PM |
| Yu Calvin | Vice President, Finance | Jul 02, 2021 | Option Exercise | $13.13 | 60,840 | 798,948 | 187,526 | Jul 07, 2021, 07:38 PM |
| Yu Calvin | Vice President, Finance | Jul 06, 2021 | Option Exercise | $13.03 | 3,334 | 43,429 | 80,020 | Jul 07, 2021, 07:38 PM |
| Yu Calvin | Vice President, Finance | Jul 06, 2021 | Sale | $34.65 | 3,334 | 115,523 | 76,686 | Jul 07, 2021, 07:38 PM |
| Yu Calvin | Vice President, Finance | Jul 02, 2021 | Sale | $32.74 | 110,840 | 3,629,078 | 96,686 | Jul 07, 2021, 07:38 PM |
| King Robert | Chief Development Officer | Jul 02, 2021 | Option Exercise | $9.15 | 60,000 | 549,000 | 582,317 | Jul 07, 2021, 07:02 PM |
| King Robert | Chief Development Officer | Jul 02, 2021 | Sale | $31.14 | 60,000 | 1,868,400 | 522,317 | Jul 07, 2021, 07:02 PM |
| Paul Robert | Chief Medical Officer | Jul 02, 2021 | Option Exercise | $17.15 | 17,326 | 297,141 | 264,319 | Jul 06, 2021, 06:14 PM |
| Paul Robert | Chief Medical Officer | Jul 02, 2021 | Sale | $31.14 | 30,000 | 934,200 | 234,319 | Jul 06, 2021, 06:14 PM |
| Paul Robert | Chief Medical Officer | Jul 01, 2021 | Sale | $22.23 | 26,726 | 594,124 | 246,993 | Jul 06, 2021, 06:14 PM |
| Paul Robert | Chief Medical Officer | Jun 08, 2021 | Option Exercise | $9.39 | 19,175 | 179,996 | 292,894 | Jun 10, 2021, 05:24 PM |
| Paul Robert | Chief Medical Officer | Jun 08, 2021 | Sale | $19.18 | 19,175 | 367,745 | 276,719 | Jun 10, 2021, 05:24 PM |
| Yu Calvin | Vice President, Finance | Jun 02, 2021 | Sale | $17.77 | 1,844 | 32,768 | 126,686 | Jun 03, 2021, 07:39 PM |
| Paul Robert | Chief Medical Officer | Apr 07, 2021 | Option Exercise | $9.60 | 22,300 | 214,186 | 236,019 | Apr 08, 2021, 08:18 PM |
| Paul Robert | Chief Medical Officer | Apr 07, 2021 | Sale | $19.20 | 22,300 | 428,050 | 213,764 | Apr 08, 2021, 08:18 PM |
| Paul Robert | Chief Medical Officer | Mar 22, 2021 | Option Exercise | $8.16 | 30,000 | 244,800 | 243,719 | Mar 24, 2021, 04:36 PM |
| Paul Robert | Chief Medical Officer | Mar 23, 2021 | Option Exercise | $8.16 | 13,800 | 112,608 | 227,519 | Mar 24, 2021, 04:36 PM |
| Paul Robert | Chief Medical Officer | Mar 22, 2021 | Sale | $22.98 | 30,000 | 689,376 | 219,229 | Mar 24, 2021, 04:36 PM |
| Paul Robert | Chief Medical Officer | Mar 23, 2021 | Sale | $22.21 | 13,800 | 306,498 | 213,719 | Mar 24, 2021, 04:36 PM |
| Paul Robert | Chief Medical Officer | Mar 09, 2021 | Option Exercise | $8.38 | 19,175 | 160,592 | 232,894 | Mar 10, 2021, 06:29 PM |
| Paul Robert | Chief Medical Officer | Mar 09, 2021 | Sale | $18.12 | 19,175 | 347,405 | 213,719 | Mar 10, 2021, 06:29 PM |
| Paul Robert | Chief Medical Officer | Feb 09, 2021 | Option Exercise | $8.38 | 19,175 | 160,594 | 232,894 | Feb 11, 2021, 05:08 PM |
| Paul Robert | Chief Medical Officer | Feb 09, 2021 | Sale | $20.81 | 19,175 | 399,055 | 213,719 | Feb 11, 2021, 05:08 PM |
| Paul Robert | Chief Medical Officer | Jan 26, 2021 | Option Exercise | $8.46 | 27,308 | 231,082 | 241,027 | Jan 27, 2021, 06:53 PM |
| Paul Robert | Chief Medical Officer | Jan 25, 2021 | Option Exercise | $8.30 | 30,000 | 248,926 | 243,719 | Jan 27, 2021, 06:53 PM |
| Paul Robert | Chief Medical Officer | Jan 26, 2021 | Sale | $18.00 | 27,308 | 491,544 | 213,719 | Jan 27, 2021, 06:53 PM |
| Paul Robert | Chief Medical Officer | Jan 25, 2021 | Sale | $18.01 | 30,000 | 540,225 | 213,719 | Jan 27, 2021, 06:53 PM |
| Paul Robert | Chief Medical Officer | Jan 19, 2021 | Option Exercise | $8.30 | 30,000 | 248,924 | 243,719 | Jan 21, 2021, 06:46 PM |
| Paul Robert | Chief Medical Officer | Jan 20, 2021 | Option Exercise | $8.64 | 8,567 | 74,031 | 222,286 | Jan 21, 2021, 06:46 PM |
| Paul Robert | Chief Medical Officer | Jan 20, 2021 | Sale | $18.00 | 8,567 | 154,211 | 213,719 | Jan 21, 2021, 06:46 PM |
| Paul Robert | Chief Medical Officer | Jan 19, 2021 | Sale | $18.12 | 30,000 | 543,552 | 213,719 | Jan 21, 2021, 06:46 PM |
| Paul Robert | Chief Medical Officer | Jul 15, 2020 | Sale | $22.96 | 10,000 | 229,642 | 214,097 | Jul 17, 2020, 04:43 PM |
| MCGUIRE TERRANCE | Director | Jun 23, 2020 | Sale | $31.54 | 4,377 | 138,063 | 12,853,817 | Jun 25, 2020, 05:53 PM |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | Jun 23, 2020 | Sale | $31.54 | 4,377 | 138,063 | 12,853,817 | Jun 25, 2020, 05:47 PM |
| Paul Robert | Chief Medical Officer | Jun 15, 2020 | Sale | $29.61 | 10,000 | 296,137 | 227,628 | Jun 17, 2020, 04:21 PM |
| Yu Calvin | Vice President, Finance | Jun 03, 2020 | Sale | $31.26 | 1,343 | 41,981 | 110,986 | Jun 05, 2020, 04:40 PM |
| Paul Robert | Chief Medical Officer | May 15, 2020 | Sale | $27.00 | 10,000 | 270,026 | 241,819 | May 19, 2020, 05:23 PM |
| King Robert | Chief Development Officer | May 15, 2020 | Sale | $27.00 | 15,000 | 404,958 | 488,952 | May 19, 2020, 05:23 PM |
| Paul Robert | Chief Medical Officer | Apr 15, 2020 | Sale | $22.27 | 10,000 | 222,700 | 243,719 | Apr 17, 2020, 05:12 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 16, 2020 | Sale | $23.53 | 62,183 | 1,463,166 | 5,955,674 | Apr 16, 2020, 08:23 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 14, 2020 | Sale | $23.52 | 23,231 | 546,393 | 6,002,771 | Apr 16, 2020, 08:23 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 08, 2020 | Sale | $23.65 | 82,614 | 1,953,821 | 6,238,574 | Apr 09, 2020, 05:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 07, 2020 | Sale | $23.10 | 9,170 | 211,827 | 6,301,147 | Apr 09, 2020, 05:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 09, 2020 | Sale | $23.79 | 288,101 | 6,853,923 | 6,020,366 | Apr 09, 2020, 05:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 31, 2020 | Sale | $24.50 | 250,000 | 6,125,000 | 6,308,093 | Apr 02, 2020, 05:06 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 25, 2020 | Sale | $24.66 | 56,411 | 1,391,095 | 6,497,448 | Mar 25, 2020, 05:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 24, 2020 | Sale | $24.45 | 67,644 | 1,653,896 | 6,540,175 | Mar 25, 2020, 05:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 23, 2020 | Sale | $26.05 | 14,598 | 380,278 | 6,591,410 | Mar 25, 2020, 05:54 PM |
| Paul Robert | Chief Medical Officer | Mar 13, 2020 | Sale | $22.93 | 10,000 | 229,286 | 262,238 | Mar 17, 2020, 07:07 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 02, 2020 | Sale | $26.00 | 1,874,203 | 48,729,278 | 6,602,467 | Mar 04, 2020, 12:00 AM |
| King Robert | Chief Development Officer | Feb 14, 2020 | Sale | $29.56 | 15,000 | 443,376 | 502,649 | Feb 18, 2020, 05:00 PM |
| Paul Robert | Chief Medical Officer | Feb 14, 2020 | Sale | $29.54 | 10,000 | 295,390 | 270,719 | Feb 18, 2020, 05:00 PM |
| Oney Sabah | Chief Business Officer | Feb 07, 2020 | Sale | $35.03 | 19,900 | 697,097 | 573,918 | Feb 11, 2020, 05:53 PM |
| Yu Calvin | Vice President, Finance | Feb 06, 2020 | Option Exercise | $8.95 | 1,821 | 16,295 | 127,115 | Feb 10, 2020, 04:42 PM |
| Yu Calvin | Vice President, Finance | Feb 07, 2020 | Option Exercise | $9.59 | 10,225 | 98,088 | 134,719 | Feb 10, 2020, 04:42 PM |
| Yu Calvin | Vice President, Finance | Feb 07, 2020 | Sale | $35.02 | 24,033 | 841,636 | 110,686 | Feb 10, 2020, 04:42 PM |
| Yu Calvin | Vice President, Finance | Feb 06, 2020 | Sale | $35.00 | 2,621 | 91,735 | 124,494 | Feb 10, 2020, 04:42 PM |
| Paul Robert | Chief Medical Officer | Feb 05, 2020 | Option Exercise | $8.16 | 10,000 | 81,600 | 283,719 | Feb 07, 2020, 08:11 PM |
| Paul Robert | Chief Medical Officer | Feb 05, 2020 | Sale | $32.10 | 10,000 | 321,000 | 273,719 | Feb 07, 2020, 08:11 PM |
| Oney Sabah | Chief Business Officer | Feb 04, 2020 | Option Exercise | $8.16 | 16,667 | 136,003 | 610,585 | Feb 06, 2020, 05:48 PM |
| Oney Sabah | Chief Business Officer | Feb 06, 2020 | Sale | $35.00 | 100 | 3,500 | 593,818 | Feb 06, 2020, 05:48 PM |
| Oney Sabah | Chief Business Officer | Feb 04, 2020 | Sale | $30.00 | 16,667 | 500,010 | 593,918 | Feb 06, 2020, 05:48 PM |
| SCHELLER RICHARD H | Director | Feb 04, 2020 | Sale | $29.67 | 10,000 | 296,700 | 9,981 | Feb 06, 2020, 05:19 PM |
| Yu Calvin | Vice President, Finance | Feb 04, 2020 | Option Exercise | $8.16 | 13,541 | 110,495 | 188,835 | Feb 06, 2020, 05:18 PM |
| Yu Calvin | Vice President, Finance | Feb 04, 2020 | Sale | $30.04 | 63,541 | 1,908,772 | 125,294 | Feb 06, 2020, 05:18 PM |
| Wehner David M. | Director | Feb 03, 2020 | Buy | $25.00 | 20,000 | 500,000 | 44,621 | Feb 03, 2020, 06:19 PM |
| Paul Robert | Chief Medical Officer | Jan 30, 2020 | Option Exercise | $8.16 | 8,000 | 65,280 | 281,719 | Feb 03, 2020, 06:14 PM |
| Paul Robert | Chief Medical Officer | Jan 30, 2020 | Sale | $28.00 | 8,000 | 224,000 | 273,719 | Feb 03, 2020, 06:14 PM |
| Oney Sabah | Chief Business Officer | Jan 27, 2020 | Option Exercise | $8.16 | 14,467 | 118,051 | 608,385 | Jan 27, 2020, 05:41 PM |
| Oney Sabah | Chief Business Officer | Jan 23, 2020 | Option Exercise | $8.16 | 2,200 | 17,952 | 596,118 | Jan 27, 2020, 05:41 PM |
| Oney Sabah | Chief Business Officer | Jan 23, 2020 | Sale | $25.21 | 2,200 | 55,462 | 593,918 | Jan 27, 2020, 05:41 PM |
| Oney Sabah | Chief Business Officer | Jan 27, 2020 | Sale | $25.05 | 14,467 | 362,398 | 593,918 | Jan 27, 2020, 05:41 PM |
| Paul Robert | Chief Medical Officer | Jan 23, 2020 | Option Exercise | $8.16 | 6,000 | 48,960 | 279,719 | Jan 27, 2020, 05:15 PM |
| Paul Robert | Chief Medical Officer | Jan 23, 2020 | Sale | $24.32 | 6,000 | 145,919 | 274,318 | Jan 27, 2020, 05:15 PM |
| King Robert | Chief Development Officer | Jan 21, 2020 | Sale | $22.01 | 14,997 | 330,084 | 507,320 | Jan 23, 2020, 04:48 PM |
| King Robert | Chief Development Officer | Jan 22, 2020 | Sale | $22.01 | 3 | 66 | 507,317 | Jan 23, 2020, 04:48 PM |
| Paul Robert | Chief Medical Officer | Jan 15, 2020 | Sale | $18.67 | 10,000 | 186,700 | 273,719 | Jan 17, 2020, 04:53 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 09, 2020 | Sale | $19.50 | 379,997 | 7,409,942 | 7,992,776 | Jan 13, 2020, 04:48 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Dec 26, 2019 | Sale | $18.60 | 10,800 | 200,880 | 8,279,563 | Dec 26, 2019, 04:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Dec 24, 2019 | Sale | $19.59 | 71,800 | 1,406,562 | 8,286,838 | Dec 26, 2019, 04:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Dec 23, 2019 | Sale | $19.82 | 94,285 | 1,868,729 | 8,335,162 | Dec 26, 2019, 04:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Dec 20, 2019 | Sale | $19.66 | 342,500 | 6,733,550 | 8,398,697 | Dec 26, 2019, 04:54 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Dec 17, 2019 | Sale | $18.52 | 954,100 | 17,669,932 | 8,629,418 | Dec 19, 2019, 04:33 PM |
| Paul Robert | Chief Medical Officer | Dec 13, 2019 | Sale | $20.03 | 10,000 | 200,300 | 283,719 | Dec 17, 2019, 05:33 PM |
| Oney Sabah | Chief Business Officer | Dec 12, 2019 | Option Exercise | $8.16 | 6,810 | 55,570 | 600,728 | Dec 16, 2019, 08:13 PM |
| Oney Sabah | Chief Business Officer | Dec 12, 2019 | Sale | $20.13 | 6,810 | 137,069 | 593,918 | Dec 16, 2019, 08:13 PM |
| Oney Sabah | Chief Business Officer | Dec 10, 2019 | Option Exercise | $8.16 | 500 | 4,080 | 594,418 | Dec 12, 2019, 04:34 PM |
| Oney Sabah | Chief Business Officer | Dec 10, 2019 | Sale | $20.01 | 500 | 10,005 | 593,918 | Dec 12, 2019, 04:34 PM |
| Oney Sabah | Chief Business Officer | Dec 09, 2019 | Option Exercise | $8.16 | 2,300 | 18,768 | 596,218 | Dec 09, 2019, 06:36 PM |
| Oney Sabah | Chief Business Officer | Dec 06, 2019 | Option Exercise | $8.16 | 5,156 | 42,073 | 599,074 | Dec 09, 2019, 06:36 PM |
| Oney Sabah | Chief Business Officer | Dec 05, 2019 | Option Exercise | $8.16 | 1,500 | 12,240 | 595,418 | Dec 09, 2019, 06:36 PM |
| Oney Sabah | Chief Business Officer | Dec 09, 2019 | Sale | $20.07 | 2,300 | 46,161 | 593,918 | Dec 09, 2019, 06:36 PM |
| Oney Sabah | Chief Business Officer | Dec 06, 2019 | Sale | $20.02 | 5,156 | 103,223 | 593,918 | Dec 09, 2019, 06:36 PM |
| Oney Sabah | Chief Business Officer | Dec 05, 2019 | Sale | $20.00 | 1,500 | 30,000 | 593,918 | Dec 09, 2019, 06:36 PM |
| Yu Calvin | Vice President, Finance | Dec 03, 2019 | Sale | $18.31 | 1,315 | 24,078 | 175,294 | Dec 05, 2019, 04:25 PM |
| King Robert | Chief Development Officer | Nov 15, 2019 | Sale | $15.92 | 7,500 | 119,400 | 522,317 | Nov 19, 2019, 04:47 PM |
| Paul Robert | Chief Medical Officer | Nov 15, 2019 | Sale | $15.93 | 10,000 | 159,300 | 293,719 | Nov 19, 2019, 04:45 PM |
| Paul Robert | Chief Medical Officer | Aug 20, 2019 | Option Exercise | $8.16 | 916 | 7,475 | 324,635 | Nov 19, 2019, 04:42 PM |
| Paul Robert | Chief Medical Officer | Aug 19, 2019 | Option Exercise | $8.16 | 1,084 | 8,845 | 324,803 | Nov 19, 2019, 04:42 PM |
| Paul Robert | Chief Medical Officer | Aug 20, 2019 | Sale | $16.00 | 916 | 14,656 | 323,719 | Nov 19, 2019, 04:42 PM |
| Paul Robert | Chief Medical Officer | Aug 19, 2019 | Sale | $16.00 | 1,084 | 17,344 | 323,719 | Nov 19, 2019, 04:42 PM |
| Paul Robert | Chief Medical Officer | Oct 15, 2019 | Sale | $14.68 | 10,000 | 146,800 | 301,719 | Oct 17, 2019, 06:15 PM |
| Oney Sabah | Chief Business Officer | Sep 20, 2019 | Option Exercise | $8.16 | 400 | 3,264 | 594,318 | Sep 24, 2019, 06:34 PM |
| Oney Sabah | Chief Business Officer | Sep 20, 2019 | Sale | $20.00 | 400 | 8,000 | 593,918 | Sep 24, 2019, 06:34 PM |
| Paul Robert | Chief Medical Officer | Sep 20, 2019 | Option Exercise | $8.16 | 4,000 | 32,640 | 315,719 | Sep 24, 2019, 06:33 PM |
| Paul Robert | Chief Medical Officer | Sep 20, 2019 | Sale | $20.00 | 4,000 | 80,000 | 311,719 | Sep 24, 2019, 06:33 PM |
| Paul Robert | Chief Medical Officer | Sep 16, 2019 | Sale | $19.08 | 10,000 | 190,800 | 311,719 | Sep 18, 2019, 05:33 PM |
| King Robert | Chief Development Officer | Aug 19, 2019 | Sale | $15.00 | 7,500 | 112,500 | 529,817 | Aug 21, 2019, 04:26 PM |
| Paul Robert | Chief Medical Officer | Aug 20, 2019 | Sale | $16.00 | 916 | 14,656 | 321,719 | Aug 21, 2019, 04:18 PM |
| Paul Robert | Chief Medical Officer | Aug 19, 2019 | Sale | $16.00 | 1,084 | 17,344 | 322,635 | Aug 21, 2019, 04:18 PM |
| Paul Robert | Chief Medical Officer | Aug 15, 2019 | Sale | $14.19 | 10,000 | 141,900 | 323,719 | Aug 19, 2019, 05:19 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Aug 07, 2019 | Sale | $17.90 | 650,000 | 11,635,000 | 9,272,225 | Aug 09, 2019, 06:41 PM |
| ORBIMED ADVISORS LLC | Director | Feb 11, 2019 | Buy | $19.00 | 411,700 | 7,822,300 | 10,434,976 | Feb 11, 2019, 07:11 PM |
| GORDON CARL L | Director | Feb 11, 2019 | Buy | $19.00 | 411,700 | 7,822,300 | 10,434,976 | Feb 11, 2019, 07:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | 09/11/2023 | 3,000,000 |
| MCGUIRE TERRANCE | Director | 09/11/2023 | 3,000,000 |
| Rosenthal Arnon | Chief Executive Officer | 09/05/2023 | 29,333 |
| Kenkare-Mitra Sara | President and Head of R&D | 09/05/2023 | 32,277 |
| Romano Gary | Chief Medical Officer | 09/05/2023 | 14,393 |
| GRASSO MARC | Chief Financial Officer | 09/05/2023 | 5,786 |
| Kenkare-Mitra Sara | President and Head of R&D | 06/02/2023 | 28,250 |
| GRASSO MARC | Chief Financial Officer | 06/02/2023 | 7,249 |
| Romano Gary | Chief Medical Officer | 06/02/2023 | 18,067 |
| Rosenthal Arnon | Chief Executive Officer | 06/02/2023 | 36,279 |
| Rosenthal Arnon | Chief Executive Officer | 03/17/2023 | 94,428 |
| Romano Gary | Chief Medical Officer | 03/02/2023 | 26,933 |
| Romano Gary | Chief Medical Officer | 12/02/2022 | 18,679 |
| Kenkare-Mitra Sara | President and Head of R&D | 03/02/2023 | 84,216 |
| GRASSO MARC | Chief Financial Officer | 03/02/2023 | 10,739 |
| Rosenthal Arnon | Chief Executive Officer | 03/02/2023 | 48,651 |
| Yaffe Kristine | Director | 09/10/2021 | 36,200 |
| Romano Gary | Chief Medical Officer | 09/02/2022 | 23,120 |
| King Robert | Chief Development Officer | 09/02/2022 | 1,869 |
| King Robert | Chief Development Officer | 06/02/2022 | 1,542 |
| King Robert | Chief Development Officer | 03/01/2022 | 4,468 |
| SULIMAN SHEHNAAZ | President and COO | 12/13/2021 | 1,292,250 |
| SULIMAN SHEHNAAZ | President and COO | 12/10/2021 | 1,292,250 |
| SULIMAN SHEHNAAZ | President and COO | 12/13/2021 | 1,593,149 |
| SULIMAN SHEHNAAZ | President and COO | 12/10/2021 | 1,632,167 |
| SULIMAN SHEHNAAZ | President and COO | 12/09/2021 | 1,292,250 |
| SULIMAN SHEHNAAZ | President and COO | 12/08/2021 | 906,493 |
| SULIMAN SHEHNAAZ | President and COO | 12/08/2021 | 1,709,316 |
| SULIMAN SHEHNAAZ | President and COO | 12/09/2021 | 1,711,843 |
| King Robert | Chief Development Officer | 12/01/2021 | 5,023 |
| Rosenthal Arnon | Chief Executive Officer | 11/11/2021 | 1,375,000 |
| Rosenthal Arnon | Chief Executive Officer | 11/10/2021 | 1,375,000 |
| Rosenthal Arnon | Chief Executive Officer | 11/09/2021 | 2,500,000 |
| Rosenthal Arnon | Chief Executive Officer | 11/08/2021 | 2,500,000 |
| Rosenthal Arnon | Chief Executive Officer | 11/05/2021 | 2,500,000 |
| Rosenthal Arnon | Chief Executive Officer | 11/04/2021 | 2,500,000 |
| Rosenthal Arnon | Chief Executive Officer | 09/23/2021 | 241,567 |
| Rosenthal Arnon | Chief Executive Officer | 09/22/2021 | 2,533,188 |
| Rosenthal Arnon | Chief Executive Officer | 09/20/2021 | 2,580,391 |
| Rosenthal Arnon | Chief Executive Officer | 09/21/2021 | 2,611,437 |
| Paul Robert | Chief Medical Officer | 08/09/2021 | 245,245 |
| Paul Robert | Chief Medical Officer | 08/09/2021 | 623,767 |
| SCHELLER RICHARD H | Director | 08/05/2021 | 570,476 |
| SCHELLER RICHARD H | Director | 08/05/2021 | 1,557,341 |
| SCHELLER RICHARD H | Director | 07/02/2021 | 310,808 |
| Paul Robert | Chief Medical Officer | 07/07/2021 | 361,340 |
| Paul Robert | Chief Medical Officer | 07/06/2021 | 514,500 |
| Paul Robert | Chief Medical Officer | 07/06/2021 | 1,119,167 |
| Paul Robert | Chief Medical Officer | 07/07/2021 | 1,151,237 |
| Yu Calvin | Vice President, Finance | 07/02/2021 | 798,948 |
| Yu Calvin | Vice President, Finance | 07/06/2021 | 43,429 |
| Yu Calvin | Vice President, Finance | 07/06/2021 | 115,523 |
| Yu Calvin | Vice President, Finance | 07/02/2021 | 3,629,078 |
| King Robert | Chief Development Officer | 07/02/2021 | 549,000 |
| King Robert | Chief Development Officer | 07/02/2021 | 1,868,400 |
| Paul Robert | Chief Medical Officer | 07/02/2021 | 297,141 |
| Paul Robert | Chief Medical Officer | 07/02/2021 | 934,200 |
| Paul Robert | Chief Medical Officer | 07/01/2021 | 594,124 |
| Paul Robert | Chief Medical Officer | 06/08/2021 | 179,996 |
| Paul Robert | Chief Medical Officer | 06/08/2021 | 367,745 |
| Yu Calvin | Vice President, Finance | 06/02/2021 | 32,768 |
| Paul Robert | Chief Medical Officer | 04/07/2021 | 214,186 |
| Paul Robert | Chief Medical Officer | 04/07/2021 | 428,050 |
| Paul Robert | Chief Medical Officer | 03/22/2021 | 244,800 |
| Paul Robert | Chief Medical Officer | 03/23/2021 | 112,608 |
| Paul Robert | Chief Medical Officer | 03/22/2021 | 689,376 |
| Paul Robert | Chief Medical Officer | 03/23/2021 | 306,498 |
| Paul Robert | Chief Medical Officer | 03/09/2021 | 160,592 |
| Paul Robert | Chief Medical Officer | 03/09/2021 | 347,405 |
| Paul Robert | Chief Medical Officer | 02/09/2021 | 160,594 |
| Paul Robert | Chief Medical Officer | 02/09/2021 | 399,055 |
| Paul Robert | Chief Medical Officer | 01/26/2021 | 231,082 |
| Paul Robert | Chief Medical Officer | 01/25/2021 | 248,926 |
| Paul Robert | Chief Medical Officer | 01/26/2021 | 491,544 |
| Paul Robert | Chief Medical Officer | 01/25/2021 | 540,225 |
| Paul Robert | Chief Medical Officer | 01/19/2021 | 248,924 |
| Paul Robert | Chief Medical Officer | 01/20/2021 | 74,031 |
| Paul Robert | Chief Medical Officer | 01/20/2021 | 154,211 |
| Paul Robert | Chief Medical Officer | 01/19/2021 | 543,552 |
| Paul Robert | Chief Medical Officer | 07/15/2020 | 229,642 |
| MCGUIRE TERRANCE | Director | 06/23/2020 | 138,063 |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | 06/23/2020 | 138,063 |
| Paul Robert | Chief Medical Officer | 06/15/2020 | 296,137 |
| Yu Calvin | Vice President, Finance | 06/03/2020 | 41,981 |
| Paul Robert | Chief Medical Officer | 05/15/2020 | 270,026 |
| King Robert | Chief Development Officer | 05/15/2020 | 404,958 |
| Paul Robert | Chief Medical Officer | 04/15/2020 | 222,700 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/16/2020 | 1,463,166 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/14/2020 | 546,393 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/08/2020 | 1,953,821 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/07/2020 | 211,827 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/09/2020 | 6,853,923 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/31/2020 | 6,125,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/25/2020 | 1,391,095 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/24/2020 | 1,653,896 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/23/2020 | 380,278 |
| Paul Robert | Chief Medical Officer | 03/13/2020 | 229,286 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/02/2020 | 48,729,278 |
| King Robert | Chief Development Officer | 02/14/2020 | 443,376 |
| Paul Robert | Chief Medical Officer | 02/14/2020 | 295,390 |
| Oney Sabah | Chief Business Officer | 02/07/2020 | 697,097 |
| Yu Calvin | Vice President, Finance | 02/06/2020 | 16,295 |
| Yu Calvin | Vice President, Finance | 02/07/2020 | 98,088 |
| Yu Calvin | Vice President, Finance | 02/07/2020 | 841,636 |
| Yu Calvin | Vice President, Finance | 02/06/2020 | 91,735 |
| Paul Robert | Chief Medical Officer | 02/05/2020 | 81,600 |
| Paul Robert | Chief Medical Officer | 02/05/2020 | 321,000 |
| Oney Sabah | Chief Business Officer | 02/04/2020 | 136,003 |
| Oney Sabah | Chief Business Officer | 02/06/2020 | 3,500 |
| Oney Sabah | Chief Business Officer | 02/04/2020 | 500,010 |
| SCHELLER RICHARD H | Director | 02/04/2020 | 296,700 |
| Yu Calvin | Vice President, Finance | 02/04/2020 | 110,495 |
| Yu Calvin | Vice President, Finance | 02/04/2020 | 1,908,772 |
| Wehner David M. | Director | 02/03/2020 | 500,000 |
| Paul Robert | Chief Medical Officer | 01/30/2020 | 65,280 |
| Paul Robert | Chief Medical Officer | 01/30/2020 | 224,000 |
| Oney Sabah | Chief Business Officer | 01/27/2020 | 118,051 |
| Oney Sabah | Chief Business Officer | 01/23/2020 | 17,952 |
| Oney Sabah | Chief Business Officer | 01/23/2020 | 55,462 |
| Oney Sabah | Chief Business Officer | 01/27/2020 | 362,398 |
| Paul Robert | Chief Medical Officer | 01/23/2020 | 48,960 |
| Paul Robert | Chief Medical Officer | 01/23/2020 | 145,919 |
| King Robert | Chief Development Officer | 01/21/2020 | 330,084 |
| King Robert | Chief Development Officer | 01/22/2020 | 66 |
| Paul Robert | Chief Medical Officer | 01/15/2020 | 186,700 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/09/2020 | 7,409,942 |
| ORBIMED ADVISORS LLC | 10% Owner | 12/26/2019 | 200,880 |
| ORBIMED ADVISORS LLC | 10% Owner | 12/24/2019 | 1,406,562 |
| ORBIMED ADVISORS LLC | 10% Owner | 12/23/2019 | 1,868,729 |
| ORBIMED ADVISORS LLC | 10% Owner | 12/20/2019 | 6,733,550 |
| ORBIMED ADVISORS LLC | 10% Owner | 12/17/2019 | 17,669,932 |
| Paul Robert | Chief Medical Officer | 12/13/2019 | 200,300 |
| Oney Sabah | Chief Business Officer | 12/12/2019 | 55,570 |
| Oney Sabah | Chief Business Officer | 12/12/2019 | 137,069 |
| Oney Sabah | Chief Business Officer | 12/10/2019 | 4,080 |
| Oney Sabah | Chief Business Officer | 12/10/2019 | 10,005 |
| Oney Sabah | Chief Business Officer | 12/09/2019 | 18,768 |
| Oney Sabah | Chief Business Officer | 12/06/2019 | 42,073 |
| Oney Sabah | Chief Business Officer | 12/05/2019 | 12,240 |
| Oney Sabah | Chief Business Officer | 12/09/2019 | 46,161 |
| Oney Sabah | Chief Business Officer | 12/06/2019 | 103,223 |
| Oney Sabah | Chief Business Officer | 12/05/2019 | 30,000 |
| Yu Calvin | Vice President, Finance | 12/03/2019 | 24,078 |
| King Robert | Chief Development Officer | 11/15/2019 | 119,400 |
| Paul Robert | Chief Medical Officer | 11/15/2019 | 159,300 |
| Paul Robert | Chief Medical Officer | 08/20/2019 | 7,475 |
| Paul Robert | Chief Medical Officer | 08/19/2019 | 8,845 |
| Paul Robert | Chief Medical Officer | 08/20/2019 | 14,656 |
| Paul Robert | Chief Medical Officer | 08/19/2019 | 17,344 |
| Paul Robert | Chief Medical Officer | 10/15/2019 | 146,800 |
| Oney Sabah | Chief Business Officer | 09/20/2019 | 3,264 |
| Oney Sabah | Chief Business Officer | 09/20/2019 | 8,000 |
| Paul Robert | Chief Medical Officer | 09/20/2019 | 32,640 |
| Paul Robert | Chief Medical Officer | 09/20/2019 | 80,000 |
| Paul Robert | Chief Medical Officer | 09/16/2019 | 190,800 |
| King Robert | Chief Development Officer | 08/19/2019 | 112,500 |
| Paul Robert | Chief Medical Officer | 08/20/2019 | 14,656 |
| Paul Robert | Chief Medical Officer | 08/19/2019 | 17,344 |
| Paul Robert | Chief Medical Officer | 08/15/2019 | 141,900 |
| ORBIMED ADVISORS LLC | 10% Owner | 08/07/2019 | 11,635,000 |
| ORBIMED ADVISORS LLC | Director | 02/11/2019 | 7,822,300 |
| GORDON CARL L | Director | 02/11/2019 | 7,822,300 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ALECTOR INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 7,825,553 | 0.0013% | 3.19% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,289,722 | 0.00091% | 5.83% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,055,192 | 0.14% | No change | Other |
| BAKER BROS. ADVISORS LP | 964,851 | 0.03% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 687,083 | 0.00595% | 5.71% | Other |
| PLATINUM INVESTMENT MANAGEMENT LTD | 181,689 | 0.04% | No change | Growth At A Reasonable Price, Value |
| AQR CAPITAL MANAGEMENT LLC | 24,201 | 0.00031% | -67.88% | Other |
| CANDRIAM S.C.A. | 68,368 | 0.0027% | Exited | Other |
| ALPS ADVISORS INC | 61,270 | 0.0032% | 12% | Other |
| D. E. SHAW & CO., INC. | 18,195 | 0.00011% | New | Other |
| BLACKSTONE INC. | 10,286 | 0.00026% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR ALECTOR INC
STOCK BUYBACKS FOR ALECTOR INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0.56%
1Q
12/31/2022
0.97%
2Q
09/30/2022
1.17%
3Q
06/30/2022
1.18%
4Q
03/31/2022
1.78%
5Q
12/31/2021
14.39%
6Q
09/30/2021
-1.96%
7Q
06/30/2021
4.73%
8Q
03/31/2021
5.26%
9Q
12/31/2020
5.76%
10Q
09/30/2020
6.09%
11Q
06/30/2020
6.57%
12Q
03/31/2020
11.69%
13Q
12/31/2019
22.99%
14Q
09/30/2019
23.67%
15Q
06/30/2019
24.12%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALECTOR INC
LOADING...